Eman Alaaeldin
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 6
- Advanced Drug Delivery Systems 5
-
- Nanoparticle-Based Drug Delivery 8
- Co-authors
- Hatem A. Sarhan (10 shared papers)Amr S. Abu Lila (5 shared papers)Tatsuhiro Ishida (5 shared papers)Taro Shimizu (3 shared papers)Amal K. Hussein (2 shared papers)János Szebeni (1 shared paper)Heba F. Mansour (6 shared papers)Fatma M. Mady (3 shared papers)
- Journals
- AAPS PharmSciTech (3 papers)International Journal of Pharmaceutics (3 papers)International Journal of Nanomedicine (3 papers)Pharmaceutics (2 papers)Journal of Controlled Release (2 papers)
- Partner nations
- EgyptSaudi ArabiaJapan
In The Last Decade
Eman Alaaeldin
30 papers receiving 971 citations
Eman Alaaeldin's Hit Papers
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 183
- Biomaterials 288
- Insect Science 107
- Toxicology 28
- Complementary and alternative medicine 54
Countries citing papers authored by Eman Alaaeldin
This map shows the geographic impact of Eman Alaaeldin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman Alaaeldin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman Alaaeldin more than expected).
Fields of papers citing papers by Eman Alaaeldin
This network shows the impact of papers produced by Eman Alaaeldin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman Alaaeldin. The network helps show where Eman Alaaeldin may publish in the future.
Co-authors
The 25 scholars most cited alongside Eman Alaaeldin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PEGylated liposomes: immunological responses Hit paper breakdown → | 2019 | 384 |
| 2 | 2020 | 87 | |
| 3 | 2021 | 60 | |
| 4 | 2018 | 50 | |
| 5 | 2019 | 50 | |
| 6 | 2021 | 45 | |
| 7 | 2020 | 44 | |
| 8 | 2019 | 40 | |
| 9 | 2023 | 26 | |
| 10 | 2021 | 24 | |
| 11 | 2021 | 22 | |
| 12 | 2022 | 18 | |
| 13 | 2022 | 18 | |
| 14 | 2021 | 15 | |
| 15 | 2021 | 14 | |
| 16 | 2013 | 14 | |
| 17 | 2020 | 13 | |
| 18 | 2022 | 12 | |
| 19 | 2017 | 7 | |
| 20 | 2022 | 7 |
About Eman Alaaeldin
Eman Alaaeldin is a scholar working on Pharmaceutical Science, Biomaterials, Food Science, Molecular Biology and Complementary and alternative medicine, having authored 30 papers that have together received 980 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Essential Oils and Antimicrobial Activity (7 papers), Advancements in Transdermal Drug Delivery (6 papers), Nigella sativa pharmacological applications (5 papers), Advanced Drug Delivery Systems (5 papers), Bee Products Chemical Analysis (4 papers), Bioactive Compounds and Antitumor Agents (4 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Pharmaceutical Science (183 citations), Biomaterials (288 citations), Insect Science (107 citations), Toxicology (28 citations) and Complementary and alternative medicine (54 citations). Eman Alaaeldin has collaborated with scholars based in Egypt, Saudi Arabia and Japan. Frequent co-authors include Hatem A. Sarhan, Amr S. Abu Lila, Tatsuhiro Ishida, Taro Shimizu, Amal K. Hussein, János Szebeni, Heba F. Mansour, Fatma M. Mady, Heba S. Rateb and Mahmoud M. A. Elsayed. Their work appears in journals such as AAPS PharmSciTech, International Journal of Pharmaceutics, International Journal of Nanomedicine, Pharmaceutics and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.